← Back to Search

Other

Computer-Assisted Alcohol Administration Study

Phase 1
Waitlist Available
Led By Vijay A Ramchandani, Ph.D.
Research Sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2.5 hrs
Awards & highlights

Study Summary

This trial is testing the reliability of a computer-assisted method for self-administering ethanol intravenously. The study will also examine self-administration behavior and resulting breath alcohol concentration, the effects of alcohol on the participants, and differences between men and women in alcohol self-administration.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2.5 hrs
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2.5 hrs for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
BrAC Exposure (peak BrAC, Average BrAC) during self-administration
Secondary outcome measures
Subjective response during self-administration

Side effects data

From 2017 Phase 2 trial • 17 Patients • NCT01779024
59%
Increased Appetite
41%
Somnolence
35%
Euphoric mood
29%
Fatigue
12%
Memory impairment
12%
Hyperhidrosis
12%
Dizziness
12%
Nausea
6%
Feeling hot
6%
Flushing
6%
Headache
6%
Decreased appetite
100%
80%
60%
40%
20%
0%
Study treatment Arm
Ghrelin
Placebo

Trial Design

1Treatment groups
Experimental Treatment
Group I: 1Experimental Treatment1 Intervention
Alcohol
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Alcohol
2008
Completed Phase 3
~2000

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

National Institute on Alcohol Abuse and Alcoholism (NIAAA)Lead Sponsor
801 Previous Clinical Trials
1,365,168 Total Patients Enrolled
Vijay A Ramchandani, Ph.D.Principal InvestigatorNational Institute on Alcohol Abuse and Alcoholism (NIAAA)
7 Previous Clinical Trials
1,739 Total Patients Enrolled

Media Library

Alcohol (Other) Clinical Trial Eligibility Overview. Trial Name: NCT00713492 — Phase 1
Alcohol Intoxication Research Study Groups: 1
Alcohol Intoxication Clinical Trial 2023: Alcohol Highlights & Side Effects. Trial Name: NCT00713492 — Phase 1
Alcohol (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT00713492 — Phase 1

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How detrimental is consumption of Alcohol to one's health?

"Despite a lack of evidence for efficacy and safety, our team at Power gave Alcohol an assessment score of 1."

Answered by AI

What is the approximate sample size of this medical research?

"That is correct. Data accessible on clinicaltrials.gov reveals that this medical trial, which was first posted on October 29th 2008, is actively seeking participants. Approximately 320 people must be enrolled from 2 distinct sites."

Answered by AI

Is the age bracket for this research restricted to adults?

"This medical trial will only accept participants aged 21 to 60. For those below the age of majority or above retirement, there are 7 and 16 alternative clinical trials respectively that may be suitable for them."

Answered by AI

Is it possible to become a participant in this research endeavor?

"This investigation demands 320 participants aged 21 to 60 with an alcohol dependence. The subgroups within this sample include 20 males and females between the ages of 21-45, who had binged in the last month as defined by 4 drinks for women and 5 drinks for men, plus another group of 20 that abstained from binge drinking over the same time period. All subjects must be healthy social drinkers with a normal menstrual cycle; this is especially important for female participants whose urine pregnancy test results have to return negative at the outset of their study session before it commences during their follicular phase."

Answered by AI

What therapeutic purposes does Alcohol usually serve?

"Ethanol, or Alcohol, is a viable treatment option for obstructive hypertrophic cardiomyopathy, communicable diseases, and ethylene glycol intoxication."

Answered by AI

Is enrollment open for this experimental trial?

"According to data on clinicaltrials.gov, this research project is currently gathering participants and has been active since October 29th 2008. The information was last updated as recently as November 15th 2022."

Answered by AI
~14 spots leftby Apr 2025